Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | %Female (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
84 | Environmental Carcinogenesis and Ecotoxicology Reviews | journal | 0.709 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
83 | Hormones and Cancer | journal | 0.716 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
82 | Journal of global oncology | journal | 0.576 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
81 | NanoWorld Journal | journal | 6 | 9 | 0 | 166 | 0 | 0 | 0.00 | 18.44 | 21.43 | ||
80 | World Cancer Research Journal | journal | 13 | 38 | 0 | 1421 | 0 | 0 | 0.00 | 37.39 | 37.50 | ||
79 | American Journal of Blood Research | journal | 1.590 Q2 | 6 | 0 | 1 | 0 | 4 | 1 | 0.00 | 0.00 | 0.00 | |
78 | Annual review of biomedical data science | journal | 22 | 11 | 6 | 1533 | 30 | 6 | 5.00 | 139.36 | 25.00 | ||
77 | National Toxicology Program technical report series | journal | 22 | 1 | 6 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | ||
76 | Journal of Immunotherapy and Precision Oncology | journal | 9 | 25 | 12 | 810 | 17 | 11 | 1.42 | 32.40 | 44.04 | ||
75 | Advances in Cancer Research | journal | 0.893 Q3 | 109 | 30 | 104 | 5564 | 562 | 13 | 5.10 | 185.47 | 0.00 | |
74 | Journal of the National Cancer Institute. Monographs | journal | 0.875 Q3 | 95 | 23 | 17 | 1798 | 73 | 17 | 4.29 | 78.17 | 47.62 | |
73 | Cancer Drug Resistance | journal | 24 | 84 | 18 | 8770 | 28 | 18 | 1.56 | 104.40 | 48.06 | ||
72 | Oncoscience (discontinued) | journal | 0.940 Q3 | 34 | 0 | 103 | 0 | 162 | 43 | 1.43 | 0.00 | 0.00 | |
71 | Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis | journal | 59 | 17 | 47 | 1364 | 195 | 44 | 2.50 | 80.24 | 42.25 | ||
70 | Journal of Mammary Gland Biology and Neoplasia | journal | 0.959 Q3 | 112 | 27 | 58 | 2159 | 173 | 56 | 3.21 | 79.96 | 52.89 | |
69 | Annals of Cancer Research and Therapy | journal | 0.128 Q4 | 7 | 25 | 64 | 333 | 8 | 58 | 0.10 | 13.32 | 15.38 | |
68 | Drug Resistance Updates | journal | 3.920 Q1 | 132 | 17 | 66 | 3750 | 944 | 66 | 11.09 | 220.59 | 56.94 | |
67 | Genes and Cancer | journal | 1.057 Q2 | 81 | 13 | 80 | 588 | 290 | 79 | 3.56 | 45.23 | 32.95 | |
66 | JNCI Cancer Spectrum | journal | 33 | 67 | 91 | 2754 | 109 | 79 | 1.20 | 41.10 | 52.30 | ||
65 | Current Pathobiology Reports | journal | 0.974 Q3 | 33 | 14 | 87 | 1073 | 202 | 86 | 2.23 | 76.64 | 33.33 | |
64 | Journal of Experimental Therapeutics and Oncology | journal | 0.231 Q4 | 40 | 12 | 90 | 466 | 67 | 90 | 0.58 | 38.83 | 28.57 | |
63 | Critical Reviews in Oncogenesis | journal | 0.580 Q3 | 57 | 38 | 102 | 2984 | 153 | 91 | 1.03 | 78.53 | 51.49 | |
62 | Sub-Cellular Biochemistry | journal | 1.439 Q2 | 81 | 53 | 171 | 8354 | 566 | 97 | 2.62 | 157.62 | 0.00 | |
61 | Current Problems in Cancer | journal | 1.433 Q2 | 47 | 73 | 117 | 2018 | 410 | 106 | 3.18 | 27.64 | 41.91 | |
60 | Seminars in Radiation Oncology | journal | 1.202 Q2 | 103 | 42 | 131 | 2656 | 405 | 119 | 3.91 | 63.24 | 37.09 | |
59 | JCO clinical cancer informatics | journal | 0.439 Q4 | 33 | 115 | 134 | 3945 | 172 | 134 | 1.28 | 34.30 | 40.79 | |
58 | Journal of Immunotherapy | journal | 1.557 Q2 | 106 | 47 | 144 | 1527 | 568 | 144 | 4.21 | 32.49 | 36.39 | |
57 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.544 Q4 | 68 | 83 | 154 | 2631 | 287 | 148 | 1.80 | 31.70 | 43.04 | |
56 | Cancer journal (Sudbury, Mass.) | journal | 1.491 Q2 | 102 | 69 | 182 | 4022 | 531 | 161 | 3.07 | 58.29 | 46.03 | |
55 | Cancer genetics | journal | 1.230 Q2 | 52 | 74 | 187 | 2921 | 527 | 175 | 3.09 | 39.47 | 46.06 | |
54 | Cancer Investigation | journal | 0.984 Q2 | 93 | 56 | 184 | 2101 | 424 | 182 | 2.26 | 37.52 | 37.84 | |
53 | Current Hematologic Malignancy Reports | journal | 0.980 Q2 | 44 | 63 | 194 | 4228 | 548 | 192 | 2.76 | 67.11 | 42.35 | |
52 | Current Opinion in Oncology | journal | 1.275 Q2 | 104 | 88 | 208 | 4322 | 667 | 195 | 3.20 | 49.11 | 46.19 | |
51 | Stem Cell Reviews and Reports | journal | 1.408 Q2 | 87 | 70 | 222 | 5445 | 1103 | 203 | 5.08 | 77.79 | 50.68 | |
50 | Seminars in Cancer Biology | journal | 3.476 Q1 | 179 | 103 | 245 | 14235 | 2400 | 225 | 9.85 | 138.20 | 33.95 | |
49 | Genes Chromosomes and Cancer | journal | 1.639 Q2 | 130 | 100 | 245 | 6287 | 869 | 239 | 3.65 | 62.87 | 47.05 | |
48 | JCO Precision Oncology | journal | 2.585 Q1 | 48 | 226 | 268 | 7512 | 850 | 252 | 3.17 | 33.24 | 42.05 | |
47 | European Journal of Cancer Prevention | journal | 0.895 Q3 | 88 | 89 | 272 | 2945 | 629 | 256 | 2.29 | 33.09 | 46.18 | |
46 | Nuclear Medicine and Biology | journal | 0.571 Q4 | 98 | 51 | 277 | 1784 | 632 | 265 | 2.38 | 34.98 | 28.21 | |
45 | Trends in Cancer | journal | 3.961 Q1 | 90 | 90 | 279 | 6044 | 2103 | 265 | 7.32 | 67.16 | 41.43 | |
44 | Cancer Prevention Research | journal | 1.371 Q2 | 112 | 93 | 281 | 3492 | 921 | 269 | 2.98 | 37.55 | 46.37 | |
43 | Epigenetics | journal | 1.782 Q1 | 111 | 87 | 274 | 5398 | 1372 | 273 | 4.76 | 62.05 | 50.26 | |
42 | Melanoma Research | journal | 0.854 Q3 | 80 | 104 | 298 | 2945 | 766 | 275 | 2.64 | 28.32 | 48.81 | |
41 | Oncogenesis | journal | 2.118 Q1 | 67 | 71 | 278 | 3231 | 1781 | 278 | 5.91 | 45.51 | 44.24 | |
40 | Neoplasia | journal | 2.414 Q1 | 144 | 96 | 282 | 4519 | 1476 | 282 | 5.67 | 47.07 | 42.06 | |
39 | Cancer cytopathology | journal | 1.365 Q2 | 68 | 109 | 387 | 2789 | 1166 | 291 | 2.97 | 25.59 | 47.58 | |
38 | JCO Global Oncology | journal | 39 | 150 | 345 | 4291 | 558 | 296 | 1.62 | 28.61 | 42.80 | ||
37 | Nitric Oxide - Biology and Chemistry | journal | 0.899 Q3 | 110 | 105 | 303 | 6963 | 1104 | 298 | 3.58 | 66.31 | 41.80 | |
36 | Molecular Imaging and Biology | journal | 0.904 Q3 | 78 | 136 | 329 | 5073 | 986 | 319 | 2.75 | 37.30 | 34.94 | |
35 | Experimental Hematology | journal | 1.302 Q2 | 129 | 86 | 333 | 3774 | 895 | 328 | 2.86 | 43.88 | 41.79 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®